Home
/
Conditions
/ Hypertension
Cardiovascular Health
Schedule a Consultation
Hypertension
Hypertension is the most common cardiovascular diagnosis and the most commonly medicated without investigating mechanism. Every case of hypertension has a physiological cause insulin-driven sodium retention, endothelial dysfunction, cortisol-driven vasoconstriction, magnesium deficiency impairing vascular smooth muscle relaxation, or primary aldosteronism -- and identifying which mechanism is active determines which treatment actually addresses the problem.
Cardiovascular HealthMechanism-SpecificHighly Modifiable
Mechanismevery hypertension case has an identifiable cause; finding it changes the treatment
Insulininsulin-driven sodium retention is the most common overlooked metabolic driver of hypertension
Magnesiummagnesium deficiency impairs vascular smooth muscle relaxation and elevates blood pressure measurably
← Back to Conditions
Condition: Hypertension | Category: Cardiovascular Health | Reviewed by: Brian Lamkin, DO
Hypertension is not a disease of elevated blood pressure; it is a symptom of underlying vascular, metabolic, and autonomic dysregulation. Insulin resistance, magnesium deficiency, sleep apnea, aldosterone excess, and endothelial dysfunction are among the most common and most correctable root causes that are almost never evaluated before a prescription is written.
What Is Hypertension?
Hypertension is defined as a sustained systolic blood pressure above 130 mmHg or diastolic above 80 mmHg, affecting over 100 million Americans and representing the leading modifiable risk factor for stroke, myocardial infarction, heart failure, and chronic kidney disease. Despite its prevalence, conventional management rarely investigates root causes: the standard of care is pharmaceutical blood pressure reduction without characterizing the mechanisms driving the elevation.
From a functional medicine perspective, hypertension is a downstream signal of vascular inflammation, insulin resistance, autonomic imbalance, oxidative stress, and a range of treatable upstream drivers that are never identified when treatment begins and ends with antihypertensive prescription. Two patients with identical blood pressure readings can have entirely different causes requiring entirely different interventions.
Why It Matters
The Cardiovascular Consequences
- Hypertension doubles the risk of cardiovascular events independently of other risk factors through direct mechanical injury to vessel walls
- Sustained elevated pressure accelerates endothelial dysfunction, reducing nitric oxide production and vascular protective capacity
- Left ventricular hypertrophy from chronic pressure overload increases arrhythmia risk and reduces cardiac reserve
- Renal microvascular damage from sustained hypertension drives progressive kidney function decline
- Cerebrovascular disease from hypertension produces cognitive decline, white matter lesions, and stroke independently of age
- Retinal vascular damage reflects the global vascular burden of chronically elevated pressure
What Conventional Management Misses
- Root causes including insulin resistance, sleep apnea, magnesium deficiency, and aldosterone excess are almost never investigated before prescribing
- Thiazide diuretics worsen insulin resistance and potassium depletion; amplifying two common root cause drivers
- Beta-blockers worsen metabolic dysregulation in patients with insulin resistance without addressing the sympathetic driver
- Calcium channel blockers and ACE inhibitors control pressure without addressing endothelial dysfunction or oxidative stress
- The absence of root cause evaluation means blood pressure is controlled indefinitely with medications that do not resolve the underlying disease
Common Symptoms
Hemodynamic and Physical
- Elevated blood pressure readings; often discovered incidentally since hypertension is frequently asymptomatic
- Morning headaches, particularly in the occipital region, from nocturnal blood pressure elevation
- Visual disturbances or floaters from retinal microvascular changes in prolonged hypertension
- Nosebleeds in severe or suddenly elevated blood pressure
- Reduced exercise tolerance from impaired cardiac output reserve and vascular stiffness
Autonomic and Neurological
- Palpitations and heart awareness from sympathetic nervous system activation driving cardiac rate and force
- Anxiety and tension from chronic sympathetic excess contributing to the hypertensive cycle
- Brain fog and cognitive difficulties from cerebrovascular compromise and inflammatory burden
- Tinnitus associated with elevated blood pressure and vascular turbulence
- Sleep disturbance from sleep apnea contributing to nocturnal hypertensive surges
Metabolic Warning Signs
- Central weight gain with elevated waist circumference indicating the insulin resistance-hypertension phenotype
- Elevated fasting insulin and triglycerides on metabolic panel pointing to the metabolic syndrome driver
- Muscle cramping and fatigue from magnesium deficiency, a direct smooth muscle relaxant, impairing vascular tone
- Reduced libido and fatigue from the cortisol-aldosterone axis dysregulation contributing to volume-mediated hypertension
- Urinary frequency suggesting volume regulation abnormality from aldosterone excess or renal involvement
Root Causes: A Functional Medicine Perspective
Hypertension arises from the convergent output of multiple biological pathways that all ultimately impair vascular tone, renal sodium handling, cardiac output, or arterial compliance. Insulin resistance drives blood pressure elevation through direct renal sodium retention via upregulation of renal tubular sodium-hydrogen exchangers, sympathetic nervous system activation increasing heart rate and peripheral resistance, and stimulation of endothelin-1 production promoting sustained vasoconstriction. Addressing insulin resistance alone frequently produces 10-15 mmHg systolic reductions.
Magnesium deficiency impairs vascular smooth muscle relaxation, magnesium acts as a physiological calcium channel blocker in the vasculature. Sleep apnea produces nocturnal hypoxic surges with sustained sympathetic activation that maintains daytime blood pressure elevation. Primary hyperaldosteronism, present in 5-10% of hypertensive patients; drives volume-dependent hypertension that does not respond to standard antihypertensives and requires specific aldosterone-targeted treatment.
Conventional vs Functional Medicine Approach
| Domain | Conventional Medicine | Functional Medicine |
|---|---|---|
| Initial evaluation | Blood pressure measurement, basic metabolic panel, kidney function; root cause not investigated | Fasting insulin, aldosterone-to-renin ratio, RBC magnesium, sleep apnea screening, and inflammatory markers as standard first-line evaluation |
| Dietary approach | DASH diet and sodium restriction recommended; fructose, insulin, and magnesium not specifically addressed | Insulin reduction through carbohydrate modification; potassium optimization; magnesium repletion; fructose elimination as a specific driver of hepatic insulin resistance |
| Sleep | Sleep apnea treatment recommended if diagnosed; proactive screening rare | Active sleep apnea screening in all hypertensive patients; CPAP is a primary antihypertensive intervention for OSA |
| Pharmaceutical approach | First-line antihypertensives regardless of mechanism; thiazides, ACE inhibitors, CCBs selected by guideline algorithm | Pharmaceutical selection based on identified mechanism; aldosterone-driven hypertension treated differently from insulin-driven or magnesium-deficient hypertension |
| Resistant hypertension | Add medications sequentially; specialist referral; root cause rarely reconsidered | Systematic evaluation for sleep apnea, primary aldosteronism, heavy metals, and insulin resistance as the most common correctable causes of resistant hypertension |
Key Labs to Evaluate
A complete hypertension evaluation goes far beyond a basic metabolic panel. Identifying the specific mechanism driving blood pressure elevation determines which interventions will be effective.
Fasting Insulin and HOMA-IRHyperinsulinemia drives sodium retention and sympathetic activation; the most common untested driver of hypertension.
→Aldosterone-to-Renin RatioScreens for primary hyperaldosteronism; present in 5-10% of hypertensive patients and frequently missed without this test.
→Magnesium (RBC)Deficiency impairs vascular smooth muscle relaxation; serum magnesium misses deficiency until depletion is severe.
→hs-CRPVascular inflammatory burden accelerating endothelial dysfunction and arterial stiffness underlying hypertension.
→HomocysteineDirect endothelial toxin impairing nitric oxide production and accelerating vascular damage; target below 8 umol/L.
→Cortisol (AM)Elevated cortisol drives aldosterone upregulation and volume expansion; essential in adrenal-driven hypertension patterns.
→How to Interpret These Labs Together
Elevated fasting insulin with elevated triglycerides and central adiposity identifies the metabolic syndrome hypertension phenotype. The driving mechanism is insulin-mediated sodium retention and sympathetic activation, not primary vascular disease. Reducing fasting insulin through dietary carbohydrate reduction typically produces 10-15 mmHg systolic reduction without adding medications, and makes existing medications substantially more effective.
Elevated aldosterone-to-renin ratio with hypokalemia and resistant blood pressure identifies primary hyperaldosteronism as a treatable secondary cause. This pattern is present in 5-10% of hypertensive patients and is almost never evaluated in standard care. Mineralocorticoid receptor blockade or adrenal surgical intervention produces blood pressure normalization in patients who have been on multiple medications for years.
Low RBC magnesium with muscle cramping, sleep disturbance, and blood pressure unresponsive to dietary modification identifies the magnesium-deficient phenotype. Magnesium glycinate 400-600 mg nightly produces measurable blood pressure reduction within 4-8 weeks in deficient patients, and the deficiency is almost never identified because serum magnesium remains normal until total body depletion is severe.
Common Patterns Seen in Patients
- The patient on three medications whose pressure is still not controlled: sleep apnea never screened despite loud snoring, RBC magnesium in the bottom quartile, fasting insulin of 21 uIU/mL, and an elevated aldosterone-to-renin ratio; all three correctable root causes entirely unaddressed; CPAP, magnesium repletion, insulin reduction, and mineralocorticoid receptor blockade normalize blood pressure where three antihypertensives have failed
- The otherwise healthy patient with early-onset hypertension at age 35: no family history, normal weight, blood pressure of 145/92; workup reveals fasting insulin of 16 uIU/mL, RBC magnesium in the lowest quartile, and mild sleep apnea; dietary carbohydrate reduction and magnesium repletion normalize blood pressure without medication over 90 days
- The high-cortisol executive with progressive blood pressure elevation despite diet and exercise: eating clean, exercising regularly, but blood pressure rising year over year with progressive central weight gain; 4-point cortisol shows elevated afternoon values; cortisol-driven aldosterone upregulation and volume expansion is the mechanism; HPA axis restoration produces meaningful blood pressure reduction
- The patient with white coat hypertension whose home readings are normal: BP of 158/94 in clinic, 122/78 at home; standard care initiates antihypertensive prescription; home monitoring with a calibrated device and ambulatory blood pressure monitoring confirms white coat phenotype; no medication required
Treatment and Optimization Strategy
Hypertension treatment must be matched to the identified mechanism. The same dietary, pharmaceutical, and lifestyle interventions do not produce equivalent results across different hypertension phenotypes, and treating all hypertension identically while ignoring mechanism is what produces the high rates of inadequate control and polypharmacy seen in standard care.
Lifestyle and Nutritional Foundation
- Correct insulin resistance through carbohydrate reduction and resistance training; 10-15 mmHg systolic reduction is achievable through insulin normalization alone
- Increase dietary potassium from whole food sources (leafy greens, avocado, legumes) to target 3,500-5,000 mg daily to balance sodium
- Magnesium glycinate 400-600 mg nightly relaxes vascular smooth muscle and reduces blood pressure 3-4 mmHg in deficient patients within 4-8 weeks
- DASH dietary pattern produces 8-14 mmHg systolic reduction in randomized trials; effect is amplified by concurrent carbohydrate reduction and fructose elimination
- Mind-body practices including slow breathing, meditation, and yoga reduce sympathetic tone through measurable HRV improvement
Clinical Interventions
- Sleep apnea screening and CPAP initiation; OSA is present in over 50% of resistant hypertension patients and CPAP reduces blood pressure 2-5 mmHg
- Aldosterone-to-renin ratio testing to identify the 5-10% of hypertensive patients with primary hyperaldosteronism requiring targeted treatment
- Heavy metal testing and chelation when lead or cadmium burden contributes to vascular dysfunction in treatment-resistant patients
- Pharmaceutical antihypertensives selected based on identified mechanism and used as adjuncts to root cause correction rather than replacements
- L-citrulline and dietary nitrate to support endothelial nitric oxide production and improve vascular tone through non-pharmaceutical mechanisms
What Most Doctors Miss
- Root causes are never evaluated before prescribing: the average hypertension visit results in a prescription within minutes of diagnosis without investigation of insulin resistance, sleep apnea, magnesium status, or aldosterone: the most common modifiable drivers that are present in the majority of hypertensive patients
- Resistant hypertension triggers medication addition rather than root cause investigation: the standard response to a third medication not controlling blood pressure is to add a fourth; rather than evaluate for sleep apnea, aldosterone excess, and insulin resistance that explain why the first three are not working
- Thiazide diuretics worsen the metabolic driver most commonly present: hydrochlorothiazide depletes potassium and magnesium, worsens insulin resistance, and elevates uric acid; directly amplifying the three most common root causes of hypertension in metabolically unhealthy patients
- Magnesium deficiency is missed by standard testing: serum magnesium remains normal until severe whole-body depletion; RBC magnesium is the appropriate test and identifies deficiency that serum magnesium completely misses; magnesium-deficient hypertension is extremely common and extremely responsive to repletion
When to Seek Medical Care
Seek evaluation for hypertension if blood pressure exceeds 130/80 mmHg on repeated home measurement, if blood pressure has not normalized despite two or more antihypertensive medications, or if hypertension is accompanied by metabolic abnormalities including elevated fasting insulin, triglycerides, or waist circumference. These combinations indicate the metabolic driver phenotype that responds to root cause correction.
Seek prompt evaluation for blood pressure above 180/120 mmHg, hypertension with severe headache or visual changes, or blood pressure rising rapidly from a previously controlled baseline, as these may indicate hypertensive emergency or a newly active secondary cause requiring urgent investigation.
Recommended Testing
Identifying the root cause of this condition requires going beyond standard labs. The following markers provide the most clinically useful insights.
Foundational Labs
- Fasting Insulin
- HOMA-IR
- Aldosterone-to-Renin Ratio
- Magnesium (RBC)
- hs-CRP
- Cystatin C / eGFR
- Urine Microalbumin
Advanced Assessment
- Homocysteine
- Urinary Heavy Metals
- ADMA
- Oxidized LDL
- DHEA-S
- Thyroid Panel (TSH, Free T3, Free T4)
Not sure which testing applies to you?
Explore All Testing Options →Frequently Asked Questions
Can hypertension be reversed without medication?
In many cases of primary hypertension driven by insulin resistance, magnesium deficiency, sleep apnea, or dietary factors, meaningful blood pressure reduction is achievable through targeted lifestyle and nutritional intervention. Some patients achieve normalization without medication. Patients currently on antihypertensives should never stop medications without physician supervision.
What causes resistant hypertension?
Resistant hypertension, blood pressure remaining elevated despite three or more antihypertensive medications, is most commonly caused by sleep apnea, primary hyperaldosteronism, heavy metal accumulation, and unaddressed insulin resistance that were never investigated. Before adding a fourth medication, these secondary causes should be systematically evaluated.
Is sodium restriction always necessary for hypertension?
Sodium sensitivity varies significantly between individuals. Approximately 50% of hypertensive patients are sodium-sensitive and respond to sodium restriction. Increasing dietary potassium is often more effective than sodium restriction alone, and the two together produce greater reductions than either individually.
Does magnesium actually lower blood pressure?
Yes: randomized controlled trials demonstrate that magnesium supplementation reduces systolic blood pressure by 3-4 mmHg on average, with larger effects in magnesium-deficient patients. Magnesium acts as a physiological calcium channel blocker in vascular smooth muscle. RBC magnesium testing identifies deficiency that serum magnesium routinely misses.
What is white coat hypertension?
White coat hypertension refers to blood pressure elevation in clinical settings that normalizes at home. Home blood pressure monitoring with a calibrated device, or ambulatory 24-hour blood pressure monitoring, distinguishes white coat hypertension from true sustained elevation and prevents unnecessary medication in these patients.
How The Lamkin Clinic Approaches Hypertension
Clinical Perspective
When I see a patient on three blood pressure medications whose pressure is still not controlled, my first question is: what has never been measured? Ninety percent of the time, the answer includes insulin resistance, sleep apnea, magnesium status, and aldosterone. We find the driver, we address it, and the blood pressure becomes controllable, often with fewer medications, not more., Brian Lamkin, DO
Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma
Hypertension evaluation at The Lamkin Clinic begins with identification of the specific biological drivers present in that patient. Insulin resistance, endothelial function, aldosterone status, sleep quality, magnesium status, heavy metal burden, thyroid function, and inflammatory markers are all evaluated. Treatment targets the identified mechanisms. The goal is resolution of the underlying mechanism, not indefinite medication management of the downstream number.
Related Conditions
Insulin ResistanceHyperinsulinemia drives sodium retention, sympathetic activation, and vascular smooth muscle proliferation
→Endothelial DysfunctionImpaired nitric oxide production is both cause and consequence of sustained blood pressure elevation
→Metabolic SyndromeHypertension as a central diagnostic criterion of metabolic syndrome driven by shared insulin resistance root
→Cortisol DysregulationCortisol excess drives aldosterone-independent sodium retention and vascular tone dysregulation
→Oxidative StressReactive oxygen species directly impair endothelial nitric oxide synthase and promote vasoconstriction
→Sleep DisturbanceSleep apnea and poor sleep quality are independent hypertension drivers through sympathetic activation
→Related Symptoms
Chronic FatigueCardiovascular inefficiency and impaired oxygen delivery reducing cellular energy availability
→Brain FogCerebral hypoperfusion and endothelial dysfunction impairing cognitive blood flow regulation
→Chronic StressHPA axis activation maintaining elevated sympathetic tone and aldosterone driving blood pressure
→Mitochondrial DysfunctionVascular wall mitochondrial dysfunction impairing energy-dependent endothelial and smooth muscle function
→Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.
Your Blood Pressure Is a Signal, Not Just a Number
Finding the root cause changes the treatment entirely. At The Lamkin Clinic, we identify the mechanisms driving hypertension rather than simply managing the downstream number with medication.
Schedule a ConsultationMedical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.